Danish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Celiac Disease Prevention

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
Linket gemmes på udklipsholderen
Status
Sponsorer
Kuopio University Hospital
Samarbejdspartnere
University of Eastern Finland
University of Turku
Finnish Institute for Health and Welfare
Päivikki and Sakari Sohlberg Foundation, Finland
Kätilöopisto Maternity Hospital

Nøgleord

Abstrakt

Celiac disease is an autoimmune disease induced by wheat gluten. Destruction of epithelial cells and microvilli on gut mucosa is causing a "flat mucosa" and an absorption defect. The diagnosis is based on typical microscopical finding in biopsy specimens but serum antibodies to tissue transglutaminase and certain gliadin peptides are strongly associated with the pathology. Severe diarrhoea associated with growth disturbance in infancy was historically characterising the disease but is nowadays rare. Clinically more mild forms including silent disease are very common. Studies based on antibody screening and biopsies done in autoantibody positive subjects have confirmed a frequency of about 1-2% in adult population. Undiagnosed disease is associated with deficiencies of nutrients and vitamins leading to various chronic symptoms like anaemia, osteoporosis and general fatigue. It has also been recently found that undiagnosed celiac disease may be associated with general underachievement in society probably associated with common psychological symptoms like fatigue and depression during the adolescence. The disease is treated by complete elimination of wheat, rye and barley in the diet, which is laborious and causing considerable extra costs in nutrition.
Much progress has been recently made in understanding of the genetic background and immune markers associated with the disease as well as in understanding those patterns of gluten introduction in infancy, which might be connected to a high disease risk. Our aim in this study is in the first phase to identify children at high genetic risk (around 10%) and in a follow-up study to define:
1. Are the age, dose of gluten and presence of simultaneous breast feeding at the introduction of gluten associated with the risk of celiac disease?
2. Is it possible to decrease the frequency of celiac disease by nutritional counselling?
3. Is it possible to predict development of celiac disease by immunological tests before the development of mucosal lesion
If we can confirm, that optimising the conditions at the introduction of wheat gluten in infancy diet significantly reduces the disease incidence, will this have an important effect on the nutritional recommendations concerning the diet in infancy. Combining genetic screening and immunological tests might also offer a way to reduce the frequency of celiac disease and help in early diagnosis and organisation of an adequate treatment

Datoer

Sidst bekræftet: 07/31/2013
Først indsendt: 02/05/2008
Anslået tilmelding indsendt: 02/14/2008
Først indsendt: 02/17/2008
Sidste opdatering indsendt: 08/21/2013
Sidste opdatering indsendt: 08/22/2013
Faktisk startdato for undersøgelsen: 09/30/2007
Anslået primær afslutningsdato: 07/31/2014
Anslået afslutningsdato for undersøgelsen: 11/30/2014

Tilstand eller sygdom

Celiac Disease

Intervention / behandling

Other: 1

Fase

-

Armgrupper

ArmIntervention / behandling
Active Comparator: 1
Optimization of gluten introduction by nutritional councelling
Other: 1
Optimization of gluten introduction by nutritional counselling
No Intervention: 2
No specific nutritional councelling. Follow-up of gluten introduction

Kriterier for støtteberettigelse

Køn, der er berettiget til undersøgelseAll
Accepterer sunde frivilligeJa
Kriterier

Inclusion Criteria:

- Presence of HLA-risk alleles DQA1*05 and DQB1*02

Exclusion Criteria:

- Lack of these HLA risk alleles

Resultat

Primære resultatforanstaltninger

1. development of transglutaminase antibodies [2-4 year age]

Sekundære resultatforanstaltninger

1. gliadin peptide antibodies [2-4 years]

2. mucosal biopsy in TGA positive childre [2-4 years]

Deltag i vores
facebook-side

Den mest komplette database med medicinske urter understøttet af videnskab

  • Arbejder på 55 sprog
  • Urtekurer, der understøttes af videnskab
  • Urtegenkendelse ved billede
  • Interaktivt GPS-kort - tag urter på stedet (kommer snart)
  • Læs videnskabelige publikationer relateret til din søgning
  • Søg medicinske urter efter deres virkninger
  • Organiser dine interesser og hold dig opdateret med nyhedsundersøgelser, kliniske forsøg og patenter

Skriv et symptom eller en sygdom, og læs om urter, der kan hjælpe, skriv en urt og se sygdomme og symptomer, den bruges mod.
* Al information er baseret på offentliggjort videnskabelig forskning

Google Play badgeApp Store badge